Atlas Trials

Yongxu Jia

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Yongxu Jia

RecordFirmDate
Iparomlimab and Tuvonralimab Injection (QL1706) Combined With DOS as Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction (NCT07776639)Yongxu Jia2026-05-10
Immune Checkpoint Inhibitors (ICIs) Retreatment in Second-line Treatment of Advanced Gastric Cancer: a Retrospective, Real-world Study (NCT06814548)Yongxu Jia2025-02-10
Association of Nutritional Status With Immune Checkpoint Inhibitor Efficacy in Metastatic Metastatic Esophagogastric Cancer. (NCT06923020)Yongxu Jia2024-10-31
A Single-arm, Multicenter Exploratory Clinical Trial of Anlotinib Combined With TQB2450 and the SOX Regimen as First-line Treatment for Advanced Gastric Cancer With Low PD-L1 Expression (NCT06939452)Yongxu Jia2023-06-07

Track Yongxu Jia automatically

Every clearance here is in the API, with alerts when new ones post.